Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Michael Stanley

Behavioral Neurology · Tufts

View

Dr. Jonathan Rosand

Neurocritical Care · Broad Institute

View

Dr. Jinsy Andrews

ALS · NYU Langone

View

Dr. Maisha Robinson

Hospice & Palliative Care · Mayo Clinic Florida

View

Dr. Michael Kentris

Epilepsy · St. Elizabeth Medical Center

View

Dr. Daniel Correa

Epilepsy · AECOM

View

Dr. Aaron Berkowitz

General Neurology · UCSF

View

Dr. Jose Hernan Posas

Sports Neurology · UVA

View

Dr. Michael Okun

Movement Disorders · UF

View

Dr. Joseph Sirven

Epilepsy · Mayo Clinic College of Medicine

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    EMDr. Eric Mcdade

    Dr. Eric Mcdade

    Neurology · Behavioral Neurology
    Washington University in St. Louis
    ericmcdade

    Research

    Technology-natives and technology-adopters: Age differences in remote cognitive assessment in Alzheimer disease

    2026

    Via Alzheimers Dement

    Research

    Remote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studies

    2026

    Via Alzheimers Dement (N Y)

    Research

    Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's disease.

    2026

    Via Alzheimer's & Dementia: The Journal of the Alzheimer's Association

    Research

    Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's disease.

    2026

    Via Alzheimer's & Dementia: The Journal of the Alzheimer's Association

    Research

    Targeting tau in Alzheimer's Disease: rationale, approach and challenges.

    2026

    Via Molecular Neurodegeneration

    Research

    15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIAN.

    2026

    Via NPJ Dementia

    Research

    Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocks.

    2026

    Via Nature Medicine

    Research

    A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA.

    2026

    Via The Lancet. Neurology

    Research

    Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease.

    2026

    Via Nature Medicine

    Research

    Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease.

    2026

    Via Neurology

    Research

    Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's Disease.

    2026

    Via medRxiv (preprint)

    Research

    Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairment.

    2026

    Via Alzheimer's Research & Therapy

    Research

    Statistical models for Alzheimer's disease clinical trials: Lessons learned from the DIAN-TU Platform Trial.

    2026

    Via Journal of Alzheimer's Disease

    Research

    GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy.

    2026

    Via Nature Communications

    Research

    Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association study.

    2026

    Via The Lancet. Neurology